M. D. Ikonomovic, W. E. Klunk, E. E. Abrahamson, C. A. Mathis, J. C. Price, N. D. Tsopelas, B. J. Lopresti, S. Ziolko, W. Bi, W. R. Paljug, M. L. Debnath, C. E. Hope, B. A. Isanski, R. L. Hamilton, and S. T. DeKosky, “Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease,” Brain 131, 1630–1645 (2008).
[Crossref]
[PubMed]
S. Oddo, A. Caccamo, J. D. Shepherd, M. P. Murphy, T. E. Golde, R. Kayed, R. Metherate, M. P. Mattson, Y. Akbari, and F. M. LaFerla, “Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction,” Neuron 39, 409–421 (2003).
[Crossref]
[PubMed]
A. Alpár, U. Ueberham, M. K. Brückner, G. Seeger, T. Arendt, and U. Gärtner, “Different dendrite and dendritic spine alterations in basal and apical arbors in mutant human amyloid precursor protein transgenic mice,” Brain Res. 1099, 189–198 (2006).
[Crossref]
[PubMed]
L. Qiang, W. Yu, A. Andreadis, M. Luo, and P. W. Baas, “Tau protects microtubules in the axon from severing by katanin,” J. Neurosci. 26, 3120–3129 (2006).
[Crossref]
[PubMed]
A. Alpár, U. Ueberham, M. K. Brückner, G. Seeger, T. Arendt, and U. Gärtner, “Different dendrite and dendritic spine alterations in basal and apical arbors in mutant human amyloid precursor protein transgenic mice,” Brain Res. 1099, 189–198 (2006).
[Crossref]
[PubMed]
C. S. Atwood, R. N. Martins, M. A. Smith, and G. Perry, “Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins,” Peptides 23, 1343–1350 (2002).
[Crossref]
[PubMed]
L. Qiang, W. Yu, A. Andreadis, M. Luo, and P. W. Baas, “Tau protects microtubules in the axon from severing by katanin,” J. Neurosci. 26, 3120–3129 (2006).
[Crossref]
[PubMed]
M. Meyer-Luehmann, T. L. Spires-Jones, C. Prada, M. Garcia-Alloza, A. de Calignon, A. Rozkalne, J. Koenigsknecht-Talboo, D. M. Holtzman, B. J. Bacskai, and B. T. Hyman, “Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer’s disease,” Nature 451, 720–724 (2008).
[Crossref]
[PubMed]
T. L. Spires, M. Meyer-Leuhmann, E. A. Stern, P. J. McLean, J. Skoch, P. T. Nguyen, B. J. Bacskai, and B. T. Hyman, “Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy,” J. Neurosci. 25, 7278–7287 (2005).
[Crossref]
[PubMed]
R. H. Christie, B. J. Bacskai, W. R. Zipfel, R. M. Williams, S. T. Kajdasz, W. W. Webb, and B. T. Hyman, “Growth arrest of individual senile plaques in a model of Alzheimer’s disease observed by in vivo multiphoton microscopy,” J. Neurosci. 21, 858–864 (2001).
[PubMed]
B. J. Bacskai, S. T. Kajdasz, R. H. Christie, C. Carter, D. Games, P. Seubert, D. Schenk, and B. T. Hyman, “Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy,” Nat. Med. 7, 369–372 (2001).
[Crossref]
[PubMed]
C. Ballatore, V. M. Lee, and J. Q. Trojanowski, “Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders,” Nat. Rev. Neurosci. 8, 663–672 (2007).
[Crossref]
[PubMed]
R. H. Takahashi, T. A. Milner, F. Li, E. E. Nam, M. A. Edgar, H. Yamaguchi, M. F. Beal, H. Xu, P. Greengard, and G. K. Gouras, “Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology,” Am. J. Pathol. 161, 1869–1879 (2002).
[Crossref]
[PubMed]
M. D. Ikonomovic, W. E. Klunk, E. E. Abrahamson, C. A. Mathis, J. C. Price, N. D. Tsopelas, B. J. Lopresti, S. Ziolko, W. Bi, W. R. Paljug, M. L. Debnath, C. E. Hope, B. A. Isanski, R. L. Hamilton, and S. T. DeKosky, “Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease,” Brain 131, 1630–1645 (2008).
[Crossref]
[PubMed]
L. M. Drach, J. Bohl, and H. H. Goebel, “The lipofuscin content of nerve cells of the inferior olivary nucleus in Alzheimer’s disease,” Dementia 5, 234–239 (1994).
[PubMed]
D. R. Borchelt, T. Ratovitski, J. van Lare, M. K. Lee, V. Gonzales, N. A. Jenkins, N. G. Copeland, D. L. Price, and S. S. Sisodia, “Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins,” Neuron 19, 939–945 (1997).
[Crossref]
[PubMed]
A. Alpár, U. Ueberham, M. K. Brückner, G. Seeger, T. Arendt, and U. Gärtner, “Different dendrite and dendritic spine alterations in basal and apical arbors in mutant human amyloid precursor protein transgenic mice,” Brain Res. 1099, 189–198 (2006).
[Crossref]
[PubMed]
G. Eichhoff, M. A. Busche, and O. Garaschuk, “In vivo calcium imaging of the aging and diseased brain,” Eur. J. Nucl. Med. Mol. Imaging 35, S99–S106 (2008).
[Crossref]
[PubMed]
S. Oddo, A. Caccamo, J. D. Shepherd, M. P. Murphy, T. E. Golde, R. Kayed, R. Metherate, M. P. Mattson, Y. Akbari, and F. M. LaFerla, “Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction,” Neuron 39, 409–421 (2003).
[Crossref]
[PubMed]
M. Meyer-Luehmann, T. L. Spires-Jones, C. Prada, M. Garcia-Alloza, A. de Calignon, A. Rozkalne, J. Koenigsknecht-Talboo, D. M. Holtzman, B. J. Bacskai, and B. T. Hyman, “Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer’s disease,” Nature 451, 720–724 (2008).
[Crossref]
[PubMed]
R. H. Takahashi, E. Capetillo-Zarate, M. T. Lin, T. A. Milner, and G. K. Gouras, “Co-occurrence of Alzheimer’s disease beta-amyloid and tau pathologies at synapses,” Neurobiol. Aging, in press (2008).
B. J. Bacskai, S. T. Kajdasz, R. H. Christie, C. Carter, D. Games, P. Seubert, D. Schenk, and B. T. Hyman, “Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy,” Nat. Med. 7, 369–372 (2001).
[Crossref]
[PubMed]
K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole, “Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice,” Science 274, 99–102 (1996).
[Crossref]
[PubMed]
J. Lewis, D. W. Dickson, W. L. Lin, L. Chisholm, A. Corral, G. Jones, S. H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton, and E. McGowan, “Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP,” Science 293, 1487–1491 (2001).
[Crossref]
[PubMed]
B. Li, M. O. Chohan, I. Grundke-Iqbal, and K. Iqbal, “Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau,” Acta Neuropathol. 113, 501–511 (2007).
[Crossref]
[PubMed]
W. R. Zipfel, R. M. Williams, R. Christie, A. Y. Nikitin, B. T. Hyman, and W. W. Webb, “Live tissue intrinsic emission microscopy using multiphoton-excited native fluorescence and second harmonic generation,” Proc. Natl. Acad. Sci. 100, 7075–7080 (2003).
[Crossref]
[PubMed]
R. H. Christie, B. J. Bacskai, W. R. Zipfel, R. M. Williams, S. T. Kajdasz, W. W. Webb, and B. T. Hyman, “Growth arrest of individual senile plaques in a model of Alzheimer’s disease observed by in vivo multiphoton microscopy,” J. Neurosci. 21, 858–864 (2001).
[PubMed]
B. J. Bacskai, S. T. Kajdasz, R. H. Christie, C. Carter, D. Games, P. Seubert, D. Schenk, and B. T. Hyman, “Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy,” Nat. Med. 7, 369–372 (2001).
[Crossref]
[PubMed]
K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole, “Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice,” Science 274, 99–102 (1996).
[Crossref]
[PubMed]
D. R. Borchelt, T. Ratovitski, J. van Lare, M. K. Lee, V. Gonzales, N. A. Jenkins, N. G. Copeland, D. L. Price, and S. S. Sisodia, “Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins,” Neuron 19, 939–945 (1997).
[Crossref]
[PubMed]
J. Lewis, D. W. Dickson, W. L. Lin, L. Chisholm, A. Corral, G. Jones, S. H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton, and E. McGowan, “Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP,” Science 293, 1487–1491 (2001).
[Crossref]
[PubMed]
T. Takano, X. Han, R. Deane, B. Zlokovic, and M. Nedergaard, “Two-photon imaging of astrocytic Ca2+ signaling and the microvasculature in experimental mice models of Alzheimer’s disease,” Ann. N.Y. Acad. Sci. 1097, 40–50 (2007).
[Crossref]
[PubMed]
M. D. Ikonomovic, W. E. Klunk, E. E. Abrahamson, C. A. Mathis, J. C. Price, N. D. Tsopelas, B. J. Lopresti, S. Ziolko, W. Bi, W. R. Paljug, M. L. Debnath, C. E. Hope, B. A. Isanski, R. L. Hamilton, and S. T. DeKosky, “Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease,” Brain 131, 1630–1645 (2008).
[Crossref]
[PubMed]
M. D. Ikonomovic, W. E. Klunk, E. E. Abrahamson, C. A. Mathis, J. C. Price, N. D. Tsopelas, B. J. Lopresti, S. Ziolko, W. Bi, W. R. Paljug, M. L. Debnath, C. E. Hope, B. A. Isanski, R. L. Hamilton, and S. T. DeKosky, “Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease,” Brain 131, 1630–1645 (2008).
[Crossref]
[PubMed]
W. Denk, J. H. Strickler, and W. W. Webb, “Two-photon laser scanning fluorescence microscopy,” Science 248, 73–76 (1990).
[Crossref]
[PubMed]
J. Lewis, D. W. Dickson, W. L. Lin, L. Chisholm, A. Corral, G. Jones, S. H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton, and E. McGowan, “Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP,” Science 293, 1487–1491 (2001).
[Crossref]
[PubMed]
M. Diez, J. Koistinaho, K. Kahn, D. Games, and T. Hökfelt, “Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F beta-amyloid precursor protein - initial observations,” Neuroscience 100, 259–286. (2003).
[Crossref]
A. C. Kwan, D. A. Dombeck, and W. W. Webb, “Polarized microtubule arrays in apical dendrites and axons,” Proc. Natl. Acad. Sci. 105, 11370–11375 (2008).
[Crossref]
[PubMed]
M. J. Levene, D. A. Dombeck, K. A. Kasischke, R. P. Molloy, and W. W. Webb, “In vivo multiphoton microscopy of deep brain tissue,” J. Neurophysiol. 91, 1908–1912 (2004).
[Crossref]
D. A. Dombeck, K. A. Kasischke, H. D. Vishwasrao, M. Ingelsson, B. T. Hyman, and W. W. Webb, “Uniform polarity microtubule assemblies imaged in native brain tissue by second-harmonic generation microscopy,” Proc. Natl. Acad. Sci. 100, 7081–7086 (2003).
[Crossref]
[PubMed]
J. H. Dowson, “A sensitive method for demonstration of senile plaques in the dementing brain,” Histopathology 5, 305–310. (1981).
[Crossref]
[PubMed]
L. M. Drach, J. Bohl, and H. H. Goebel, “The lipofuscin content of nerve cells of the inferior olivary nucleus in Alzheimer’s disease,” Dementia 5, 234–239 (1994).
[PubMed]
J. Tsai, J. Grutzendler, K. Duff, and W. B. Gan, “Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal brances,” Nat. Neurosci. 7, 1181–1183 (2004).
[Crossref]
[PubMed]
J. Lewis, D. W. Dickson, W. L. Lin, L. Chisholm, A. Corral, G. Jones, S. H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton, and E. McGowan, “Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP,” Science 293, 1487–1491 (2001).
[Crossref]
[PubMed]
K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole, “Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice,” Science 274, 99–102 (1996).
[Crossref]
[PubMed]
R. H. Takahashi, T. A. Milner, F. Li, E. E. Nam, M. A. Edgar, H. Yamaguchi, M. F. Beal, H. Xu, P. Greengard, and G. K. Gouras, “Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology,” Am. J. Pathol. 161, 1869–1879 (2002).
[Crossref]
[PubMed]
G. Eichhoff, M. A. Busche, and O. Garaschuk, “In vivo calcium imaging of the aging and diseased brain,” Eur. J. Nucl. Med. Mol. Imaging 35, S99–S106 (2008).
[Crossref]
[PubMed]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23, 577–583 (2005).
[Crossref]
[PubMed]
O. A. Shemesh, H. Erez, I Ginzburg, and M. E. Spira, “Tau-induced traffic jam reflect organelles accumulation at points of microtubule polar mismatching,” Traffic 9, 458–471 (2008).
[Crossref]
[PubMed]
K. A. Kasischke, H. D. Vishwasrao, P. J. Fisher, W. R. Zipfel, and W. W. Webb, “Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis,” Science 305, 99–103 (2004).
[Crossref]
[PubMed]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23, 577–583 (2005).
[Crossref]
[PubMed]
M. Diez, J. Koistinaho, K. Kahn, D. Games, and T. Hökfelt, “Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F beta-amyloid precursor protein - initial observations,” Neuroscience 100, 259–286. (2003).
[Crossref]
B. J. Bacskai, S. T. Kajdasz, R. H. Christie, C. Carter, D. Games, P. Seubert, D. Schenk, and B. T. Hyman, “Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy,” Nat. Med. 7, 369–372 (2001).
[Crossref]
[PubMed]
J. Grutzendler, K. Helmin, J. Tsai, and W. B. Gan, “Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer’s disease,” Ann. N. Y. Acad. Sci. 1097, 30–39 (2007).
[Crossref]
[PubMed]
J. Tsai, J. Grutzendler, K. Duff, and W. B. Gan, “Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal brances,” Nat. Neurosci. 7, 1181–1183 (2004).
[Crossref]
[PubMed]
G. Eichhoff, M. A. Busche, and O. Garaschuk, “In vivo calcium imaging of the aging and diseased brain,” Eur. J. Nucl. Med. Mol. Imaging 35, S99–S106 (2008).
[Crossref]
[PubMed]
M. Meyer-Luehmann, T. L. Spires-Jones, C. Prada, M. Garcia-Alloza, A. de Calignon, A. Rozkalne, J. Koenigsknecht-Talboo, D. M. Holtzman, B. J. Bacskai, and B. T. Hyman, “Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer’s disease,” Nature 451, 720–724 (2008).
[Crossref]
[PubMed]
A. Alpár, U. Ueberham, M. K. Brückner, G. Seeger, T. Arendt, and U. Gärtner, “Different dendrite and dendritic spine alterations in basal and apical arbors in mutant human amyloid precursor protein transgenic mice,” Brain Res. 1099, 189–198 (2006).
[Crossref]
[PubMed]
D. R. Thal, E. Ghebremedhin, C. Haass, and C. Schultz, “UV light-induced autofluorescence of full-length abeta-protein deposits in the human brain,” Clin. Neuropathol. 21, 35–40 (2002).
[PubMed]
O. A. Shemesh, H. Erez, I Ginzburg, and M. E. Spira, “Tau-induced traffic jam reflect organelles accumulation at points of microtubule polar mismatching,” Traffic 9, 458–471 (2008).
[Crossref]
[PubMed]
L. M. Drach, J. Bohl, and H. H. Goebel, “The lipofuscin content of nerve cells of the inferior olivary nucleus in Alzheimer’s disease,” Dementia 5, 234–239 (1994).
[PubMed]
S. Oddo, A. Caccamo, J. D. Shepherd, M. P. Murphy, T. E. Golde, R. Kayed, R. Metherate, M. P. Mattson, Y. Akbari, and F. M. LaFerla, “Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction,” Neuron 39, 409–421 (2003).
[Crossref]
[PubMed]
D. R. Borchelt, T. Ratovitski, J. van Lare, M. K. Lee, V. Gonzales, N. A. Jenkins, N. G. Copeland, D. L. Price, and S. S. Sisodia, “Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins,” Neuron 19, 939–945 (1997).
[Crossref]
[PubMed]
R. H. Takahashi, T. A. Milner, F. Li, E. E. Nam, M. A. Edgar, H. Yamaguchi, M. F. Beal, H. Xu, P. Greengard, and G. K. Gouras, “Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology,” Am. J. Pathol. 161, 1869–1879 (2002).
[Crossref]
[PubMed]
R. H. Takahashi, E. Capetillo-Zarate, M. T. Lin, T. A. Milner, and G. K. Gouras, “Co-occurrence of Alzheimer’s disease beta-amyloid and tau pathologies at synapses,” Neurobiol. Aging, in press (2008).
R. H. Takahashi, T. A. Milner, F. Li, E. E. Nam, M. A. Edgar, H. Yamaguchi, M. F. Beal, H. Xu, P. Greengard, and G. K. Gouras, “Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology,” Am. J. Pathol. 161, 1869–1879 (2002).
[Crossref]
[PubMed]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23, 577–583 (2005).
[Crossref]
[PubMed]
B. Li, M. O. Chohan, I. Grundke-Iqbal, and K. Iqbal, “Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau,” Acta Neuropathol. 113, 501–511 (2007).
[Crossref]
[PubMed]
J. Grutzendler, K. Helmin, J. Tsai, and W. B. Gan, “Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer’s disease,” Ann. N. Y. Acad. Sci. 1097, 30–39 (2007).
[Crossref]
[PubMed]
J. Tsai, J. Grutzendler, K. Duff, and W. B. Gan, “Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal brances,” Nat. Neurosci. 7, 1181–1183 (2004).
[Crossref]
[PubMed]
D. R. Thal, E. Ghebremedhin, C. Haass, and C. Schultz, “UV light-induced autofluorescence of full-length abeta-protein deposits in the human brain,” Clin. Neuropathol. 21, 35–40 (2002).
[PubMed]
M. D. Ikonomovic, W. E. Klunk, E. E. Abrahamson, C. A. Mathis, J. C. Price, N. D. Tsopelas, B. J. Lopresti, S. Ziolko, W. Bi, W. R. Paljug, M. L. Debnath, C. E. Hope, B. A. Isanski, R. L. Hamilton, and S. T. DeKosky, “Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease,” Brain 131, 1630–1645 (2008).
[Crossref]
[PubMed]
T. Takano, X. Han, R. Deane, B. Zlokovic, and M. Nedergaard, “Two-photon imaging of astrocytic Ca2+ signaling and the microvasculature in experimental mice models of Alzheimer’s disease,” Ann. N.Y. Acad. Sci. 1097, 40–50 (2007).
[Crossref]
[PubMed]
J. Lewis, D. W. Dickson, W. L. Lin, L. Chisholm, A. Corral, G. Jones, S. H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton, and E. McGowan, “Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP,” Science 293, 1487–1491 (2001).
[Crossref]
[PubMed]
K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole, “Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice,” Science 274, 99–102 (1996).
[Crossref]
[PubMed]
H. D. Vishwasrao, A. A. Heikal, K. A. Kasischke, and W. W. Webb, “Conformational dependence of intracellular NADH on metabolic state revealed by associated fluorescence anisotropy,” J. Biol. Chem. 280, 25119–25126 (2005).
[Crossref]
[PubMed]
J. Grutzendler, K. Helmin, J. Tsai, and W. B. Gan, “Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer’s disease,” Ann. N. Y. Acad. Sci. 1097, 30–39 (2007).
[Crossref]
[PubMed]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23, 577–583 (2005).
[Crossref]
[PubMed]
M. Diez, J. Koistinaho, K. Kahn, D. Games, and T. Hökfelt, “Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F beta-amyloid precursor protein - initial observations,” Neuroscience 100, 259–286. (2003).
[Crossref]
M. Meyer-Luehmann, T. L. Spires-Jones, C. Prada, M. Garcia-Alloza, A. de Calignon, A. Rozkalne, J. Koenigsknecht-Talboo, D. M. Holtzman, B. J. Bacskai, and B. T. Hyman, “Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer’s disease,” Nature 451, 720–724 (2008).
[Crossref]
[PubMed]
M. D. Ikonomovic, W. E. Klunk, E. E. Abrahamson, C. A. Mathis, J. C. Price, N. D. Tsopelas, B. J. Lopresti, S. Ziolko, W. Bi, W. R. Paljug, M. L. Debnath, C. E. Hope, B. A. Isanski, R. L. Hamilton, and S. T. DeKosky, “Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease,” Brain 131, 1630–1645 (2008).
[Crossref]
[PubMed]
K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole, “Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice,” Science 274, 99–102 (1996).
[Crossref]
[PubMed]
J. Lewis, D. W. Dickson, W. L. Lin, L. Chisholm, A. Corral, G. Jones, S. H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton, and E. McGowan, “Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP,” Science 293, 1487–1491 (2001).
[Crossref]
[PubMed]
M. Meyer-Luehmann, T. L. Spires-Jones, C. Prada, M. Garcia-Alloza, A. de Calignon, A. Rozkalne, J. Koenigsknecht-Talboo, D. M. Holtzman, B. J. Bacskai, and B. T. Hyman, “Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer’s disease,” Nature 451, 720–724 (2008).
[Crossref]
[PubMed]
T. L. Spires, M. Meyer-Leuhmann, E. A. Stern, P. J. McLean, J. Skoch, P. T. Nguyen, B. J. Bacskai, and B. T. Hyman, “Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy,” J. Neurosci. 25, 7278–7287 (2005).
[Crossref]
[PubMed]
W. R. Zipfel, R. M. Williams, R. Christie, A. Y. Nikitin, B. T. Hyman, and W. W. Webb, “Live tissue intrinsic emission microscopy using multiphoton-excited native fluorescence and second harmonic generation,” Proc. Natl. Acad. Sci. 100, 7075–7080 (2003).
[Crossref]
[PubMed]
D. A. Dombeck, K. A. Kasischke, H. D. Vishwasrao, M. Ingelsson, B. T. Hyman, and W. W. Webb, “Uniform polarity microtubule assemblies imaged in native brain tissue by second-harmonic generation microscopy,” Proc. Natl. Acad. Sci. 100, 7081–7086 (2003).
[Crossref]
[PubMed]
R. H. Christie, B. J. Bacskai, W. R. Zipfel, R. M. Williams, S. T. Kajdasz, W. W. Webb, and B. T. Hyman, “Growth arrest of individual senile plaques in a model of Alzheimer’s disease observed by in vivo multiphoton microscopy,” J. Neurosci. 21, 858–864 (2001).
[PubMed]
B. J. Bacskai, S. T. Kajdasz, R. H. Christie, C. Carter, D. Games, P. Seubert, D. Schenk, and B. T. Hyman, “Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy,” Nat. Med. 7, 369–372 (2001).
[Crossref]
[PubMed]
M. D. Ikonomovic, W. E. Klunk, E. E. Abrahamson, C. A. Mathis, J. C. Price, N. D. Tsopelas, B. J. Lopresti, S. Ziolko, W. Bi, W. R. Paljug, M. L. Debnath, C. E. Hope, B. A. Isanski, R. L. Hamilton, and S. T. DeKosky, “Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease,” Brain 131, 1630–1645 (2008).
[Crossref]
[PubMed]
D. A. Dombeck, K. A. Kasischke, H. D. Vishwasrao, M. Ingelsson, B. T. Hyman, and W. W. Webb, “Uniform polarity microtubule assemblies imaged in native brain tissue by second-harmonic generation microscopy,” Proc. Natl. Acad. Sci. 100, 7081–7086 (2003).
[Crossref]
[PubMed]
B. Li, M. O. Chohan, I. Grundke-Iqbal, and K. Iqbal, “Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau,” Acta Neuropathol. 113, 501–511 (2007).
[Crossref]
[PubMed]
M. D. Ikonomovic, W. E. Klunk, E. E. Abrahamson, C. A. Mathis, J. C. Price, N. D. Tsopelas, B. J. Lopresti, S. Ziolko, W. Bi, W. R. Paljug, M. L. Debnath, C. E. Hope, B. A. Isanski, R. L. Hamilton, and S. T. DeKosky, “Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease,” Brain 131, 1630–1645 (2008).
[Crossref]
[PubMed]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23, 577–583 (2005).
[Crossref]
[PubMed]
D. R. Borchelt, T. Ratovitski, J. van Lare, M. K. Lee, V. Gonzales, N. A. Jenkins, N. G. Copeland, D. L. Price, and S. S. Sisodia, “Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins,” Neuron 19, 939–945 (1997).
[Crossref]
[PubMed]
J. Lewis, D. W. Dickson, W. L. Lin, L. Chisholm, A. Corral, G. Jones, S. H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton, and E. McGowan, “Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP,” Science 293, 1487–1491 (2001).
[Crossref]
[PubMed]
M. Diez, J. Koistinaho, K. Kahn, D. Games, and T. Hökfelt, “Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F beta-amyloid precursor protein - initial observations,” Neuroscience 100, 259–286. (2003).
[Crossref]
R. H. Christie, B. J. Bacskai, W. R. Zipfel, R. M. Williams, S. T. Kajdasz, W. W. Webb, and B. T. Hyman, “Growth arrest of individual senile plaques in a model of Alzheimer’s disease observed by in vivo multiphoton microscopy,” J. Neurosci. 21, 858–864 (2001).
[PubMed]
B. J. Bacskai, S. T. Kajdasz, R. H. Christie, C. Carter, D. Games, P. Seubert, D. Schenk, and B. T. Hyman, “Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy,” Nat. Med. 7, 369–372 (2001).
[Crossref]
[PubMed]
H. D. Vishwasrao, A. A. Heikal, K. A. Kasischke, and W. W. Webb, “Conformational dependence of intracellular NADH on metabolic state revealed by associated fluorescence anisotropy,” J. Biol. Chem. 280, 25119–25126 (2005).
[Crossref]
[PubMed]
K. A. Kasischke, H. D. Vishwasrao, P. J. Fisher, W. R. Zipfel, and W. W. Webb, “Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis,” Science 305, 99–103 (2004).
[Crossref]
[PubMed]
M. J. Levene, D. A. Dombeck, K. A. Kasischke, R. P. Molloy, and W. W. Webb, “In vivo multiphoton microscopy of deep brain tissue,” J. Neurophysiol. 91, 1908–1912 (2004).
[Crossref]
D. A. Dombeck, K. A. Kasischke, H. D. Vishwasrao, M. Ingelsson, B. T. Hyman, and W. W. Webb, “Uniform polarity microtubule assemblies imaged in native brain tissue by second-harmonic generation microscopy,” Proc. Natl. Acad. Sci. 100, 7081–7086 (2003).
[Crossref]
[PubMed]
S. Oddo, A. Caccamo, J. D. Shepherd, M. P. Murphy, T. E. Golde, R. Kayed, R. Metherate, M. P. Mattson, Y. Akbari, and F. M. LaFerla, “Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction,” Neuron 39, 409–421 (2003).
[Crossref]
[PubMed]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23, 577–583 (2005).
[Crossref]
[PubMed]
M. D. Ikonomovic, W. E. Klunk, E. E. Abrahamson, C. A. Mathis, J. C. Price, N. D. Tsopelas, B. J. Lopresti, S. Ziolko, W. Bi, W. R. Paljug, M. L. Debnath, C. E. Hope, B. A. Isanski, R. L. Hamilton, and S. T. DeKosky, “Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease,” Brain 131, 1630–1645 (2008).
[Crossref]
[PubMed]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23, 577–583 (2005).
[Crossref]
[PubMed]
M. Meyer-Luehmann, T. L. Spires-Jones, C. Prada, M. Garcia-Alloza, A. de Calignon, A. Rozkalne, J. Koenigsknecht-Talboo, D. M. Holtzman, B. J. Bacskai, and B. T. Hyman, “Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer’s disease,” Nature 451, 720–724 (2008).
[Crossref]
[PubMed]
M. Diez, J. Koistinaho, K. Kahn, D. Games, and T. Hökfelt, “Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F beta-amyloid precursor protein - initial observations,” Neuroscience 100, 259–286. (2003).
[Crossref]
A. C. Kwan, D. A. Dombeck, and W. W. Webb, “Polarized microtubule arrays in apical dendrites and axons,” Proc. Natl. Acad. Sci. 105, 11370–11375 (2008).
[Crossref]
[PubMed]
S. Oddo, A. Caccamo, J. D. Shepherd, M. P. Murphy, T. E. Golde, R. Kayed, R. Metherate, M. P. Mattson, Y. Akbari, and F. M. LaFerla, “Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction,” Neuron 39, 409–421 (2003).
[Crossref]
[PubMed]
D. R. Borchelt, T. Ratovitski, J. van Lare, M. K. Lee, V. Gonzales, N. A. Jenkins, N. G. Copeland, D. L. Price, and S. S. Sisodia, “Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins,” Neuron 19, 939–945 (1997).
[Crossref]
[PubMed]
D. R. Borchelt, T. Ratovitski, J. van Lare, M. K. Lee, V. Gonzales, N. A. Jenkins, N. G. Copeland, D. L. Price, and S. S. Sisodia, “Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins,” Neuron 19, 939–945 (1997).
[Crossref]
[PubMed]
C. Ballatore, V. M. Lee, and J. Q. Trojanowski, “Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders,” Nat. Rev. Neurosci. 8, 663–672 (2007).
[Crossref]
[PubMed]
M. J. Levene, D. A. Dombeck, K. A. Kasischke, R. P. Molloy, and W. W. Webb, “In vivo multiphoton microscopy of deep brain tissue,” J. Neurophysiol. 91, 1908–1912 (2004).
[Crossref]
J. Lewis, D. W. Dickson, W. L. Lin, L. Chisholm, A. Corral, G. Jones, S. H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton, and E. McGowan, “Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP,” Science 293, 1487–1491 (2001).
[Crossref]
[PubMed]
B. Li, M. O. Chohan, I. Grundke-Iqbal, and K. Iqbal, “Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau,” Acta Neuropathol. 113, 501–511 (2007).
[Crossref]
[PubMed]
R. H. Takahashi, T. A. Milner, F. Li, E. E. Nam, M. A. Edgar, H. Yamaguchi, M. F. Beal, H. Xu, P. Greengard, and G. K. Gouras, “Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology,” Am. J. Pathol. 161, 1869–1879 (2002).
[Crossref]
[PubMed]
R. H. Takahashi, E. Capetillo-Zarate, M. T. Lin, T. A. Milner, and G. K. Gouras, “Co-occurrence of Alzheimer’s disease beta-amyloid and tau pathologies at synapses,” Neurobiol. Aging, in press (2008).
J. Lewis, D. W. Dickson, W. L. Lin, L. Chisholm, A. Corral, G. Jones, S. H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton, and E. McGowan, “Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP,” Science 293, 1487–1491 (2001).
[Crossref]
[PubMed]
M. D. Ikonomovic, W. E. Klunk, E. E. Abrahamson, C. A. Mathis, J. C. Price, N. D. Tsopelas, B. J. Lopresti, S. Ziolko, W. Bi, W. R. Paljug, M. L. Debnath, C. E. Hope, B. A. Isanski, R. L. Hamilton, and S. T. DeKosky, “Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease,” Brain 131, 1630–1645 (2008).
[Crossref]
[PubMed]
L. Qiang, W. Yu, A. Andreadis, M. Luo, and P. W. Baas, “Tau protects microtubules in the axon from severing by katanin,” J. Neurosci. 26, 3120–3129 (2006).
[Crossref]
[PubMed]
C. S. Atwood, R. N. Martins, M. A. Smith, and G. Perry, “Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins,” Peptides 23, 1343–1350 (2002).
[Crossref]
[PubMed]
M. D. Ikonomovic, W. E. Klunk, E. E. Abrahamson, C. A. Mathis, J. C. Price, N. D. Tsopelas, B. J. Lopresti, S. Ziolko, W. Bi, W. R. Paljug, M. L. Debnath, C. E. Hope, B. A. Isanski, R. L. Hamilton, and S. T. DeKosky, “Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease,” Brain 131, 1630–1645 (2008).
[Crossref]
[PubMed]
S. Oddo, A. Caccamo, J. D. Shepherd, M. P. Murphy, T. E. Golde, R. Kayed, R. Metherate, M. P. Mattson, Y. Akbari, and F. M. LaFerla, “Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction,” Neuron 39, 409–421 (2003).
[Crossref]
[PubMed]
J. Lewis, D. W. Dickson, W. L. Lin, L. Chisholm, A. Corral, G. Jones, S. H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton, and E. McGowan, “Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP,” Science 293, 1487–1491 (2001).
[Crossref]
[PubMed]
T. L. Spires, M. Meyer-Leuhmann, E. A. Stern, P. J. McLean, J. Skoch, P. T. Nguyen, B. J. Bacskai, and B. T. Hyman, “Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy,” J. Neurosci. 25, 7278–7287 (2005).
[Crossref]
[PubMed]
S. Oddo, A. Caccamo, J. D. Shepherd, M. P. Murphy, T. E. Golde, R. Kayed, R. Metherate, M. P. Mattson, Y. Akbari, and F. M. LaFerla, “Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction,” Neuron 39, 409–421 (2003).
[Crossref]
[PubMed]
T. L. Spires, M. Meyer-Leuhmann, E. A. Stern, P. J. McLean, J. Skoch, P. T. Nguyen, B. J. Bacskai, and B. T. Hyman, “Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy,” J. Neurosci. 25, 7278–7287 (2005).
[Crossref]
[PubMed]
M. Meyer-Luehmann, T. L. Spires-Jones, C. Prada, M. Garcia-Alloza, A. de Calignon, A. Rozkalne, J. Koenigsknecht-Talboo, D. M. Holtzman, B. J. Bacskai, and B. T. Hyman, “Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer’s disease,” Nature 451, 720–724 (2008).
[Crossref]
[PubMed]
R. H. Takahashi, T. A. Milner, F. Li, E. E. Nam, M. A. Edgar, H. Yamaguchi, M. F. Beal, H. Xu, P. Greengard, and G. K. Gouras, “Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology,” Am. J. Pathol. 161, 1869–1879 (2002).
[Crossref]
[PubMed]
R. H. Takahashi, E. Capetillo-Zarate, M. T. Lin, T. A. Milner, and G. K. Gouras, “Co-occurrence of Alzheimer’s disease beta-amyloid and tau pathologies at synapses,” Neurobiol. Aging, in press (2008).
M. J. Levene, D. A. Dombeck, K. A. Kasischke, R. P. Molloy, and W. W. Webb, “In vivo multiphoton microscopy of deep brain tissue,” J. Neurophysiol. 91, 1908–1912 (2004).
[Crossref]
S. Oddo, A. Caccamo, J. D. Shepherd, M. P. Murphy, T. E. Golde, R. Kayed, R. Metherate, M. P. Mattson, Y. Akbari, and F. M. LaFerla, “Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction,” Neuron 39, 409–421 (2003).
[Crossref]
[PubMed]
R. H. Takahashi, T. A. Milner, F. Li, E. E. Nam, M. A. Edgar, H. Yamaguchi, M. F. Beal, H. Xu, P. Greengard, and G. K. Gouras, “Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology,” Am. J. Pathol. 161, 1869–1879 (2002).
[Crossref]
[PubMed]
T. Takano, X. Han, R. Deane, B. Zlokovic, and M. Nedergaard, “Two-photon imaging of astrocytic Ca2+ signaling and the microvasculature in experimental mice models of Alzheimer’s disease,” Ann. N.Y. Acad. Sci. 1097, 40–50 (2007).
[Crossref]
[PubMed]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23, 577–583 (2005).
[Crossref]
[PubMed]
T. L. Spires, M. Meyer-Leuhmann, E. A. Stern, P. J. McLean, J. Skoch, P. T. Nguyen, B. J. Bacskai, and B. T. Hyman, “Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy,” J. Neurosci. 25, 7278–7287 (2005).
[Crossref]
[PubMed]
W. R. Zipfel, R. M. Williams, R. Christie, A. Y. Nikitin, B. T. Hyman, and W. W. Webb, “Live tissue intrinsic emission microscopy using multiphoton-excited native fluorescence and second harmonic generation,” Proc. Natl. Acad. Sci. 100, 7075–7080 (2003).
[Crossref]
[PubMed]
K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole, “Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice,” Science 274, 99–102 (1996).
[Crossref]
[PubMed]
S. Oddo, A. Caccamo, J. D. Shepherd, M. P. Murphy, T. E. Golde, R. Kayed, R. Metherate, M. P. Mattson, Y. Akbari, and F. M. LaFerla, “Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction,” Neuron 39, 409–421 (2003).
[Crossref]
[PubMed]
M. D. Ikonomovic, W. E. Klunk, E. E. Abrahamson, C. A. Mathis, J. C. Price, N. D. Tsopelas, B. J. Lopresti, S. Ziolko, W. Bi, W. R. Paljug, M. L. Debnath, C. E. Hope, B. A. Isanski, R. L. Hamilton, and S. T. DeKosky, “Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease,” Brain 131, 1630–1645 (2008).
[Crossref]
[PubMed]
C. S. Atwood, R. N. Martins, M. A. Smith, and G. Perry, “Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins,” Peptides 23, 1343–1350 (2002).
[Crossref]
[PubMed]
M. Meyer-Luehmann, T. L. Spires-Jones, C. Prada, M. Garcia-Alloza, A. de Calignon, A. Rozkalne, J. Koenigsknecht-Talboo, D. M. Holtzman, B. J. Bacskai, and B. T. Hyman, “Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer’s disease,” Nature 451, 720–724 (2008).
[Crossref]
[PubMed]
D. R. Borchelt, T. Ratovitski, J. van Lare, M. K. Lee, V. Gonzales, N. A. Jenkins, N. G. Copeland, D. L. Price, and S. S. Sisodia, “Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins,” Neuron 19, 939–945 (1997).
[Crossref]
[PubMed]
M. D. Ikonomovic, W. E. Klunk, E. E. Abrahamson, C. A. Mathis, J. C. Price, N. D. Tsopelas, B. J. Lopresti, S. Ziolko, W. Bi, W. R. Paljug, M. L. Debnath, C. E. Hope, B. A. Isanski, R. L. Hamilton, and S. T. DeKosky, “Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease,” Brain 131, 1630–1645 (2008).
[Crossref]
[PubMed]
L. Qiang, W. Yu, A. Andreadis, M. Luo, and P. W. Baas, “Tau protects microtubules in the axon from severing by katanin,” J. Neurosci. 26, 3120–3129 (2006).
[Crossref]
[PubMed]
D. R. Borchelt, T. Ratovitski, J. van Lare, M. K. Lee, V. Gonzales, N. A. Jenkins, N. G. Copeland, D. L. Price, and S. S. Sisodia, “Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins,” Neuron 19, 939–945 (1997).
[Crossref]
[PubMed]
M. Meyer-Luehmann, T. L. Spires-Jones, C. Prada, M. Garcia-Alloza, A. de Calignon, A. Rozkalne, J. Koenigsknecht-Talboo, D. M. Holtzman, B. J. Bacskai, and B. T. Hyman, “Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer’s disease,” Nature 451, 720–724 (2008).
[Crossref]
[PubMed]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23, 577–583 (2005).
[Crossref]
[PubMed]
J. Lewis, D. W. Dickson, W. L. Lin, L. Chisholm, A. Corral, G. Jones, S. H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton, and E. McGowan, “Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP,” Science 293, 1487–1491 (2001).
[Crossref]
[PubMed]
B. Sakmann and G. Stuart, “Patch-pipette recordings from the soma, dendrites and, and axon of neurons in brain slices,” in Single-Channel Recording, 2nd ed., B. Sakmann and E. Neher, eds. (Plenum, 1983), pp. 199–211.
B. J. Bacskai, S. T. Kajdasz, R. H. Christie, C. Carter, D. Games, P. Seubert, D. Schenk, and B. T. Hyman, “Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy,” Nat. Med. 7, 369–372 (2001).
[Crossref]
[PubMed]
D. R. Thal, E. Ghebremedhin, C. Haass, and C. Schultz, “UV light-induced autofluorescence of full-length abeta-protein deposits in the human brain,” Clin. Neuropathol. 21, 35–40 (2002).
[PubMed]
A. Alpár, U. Ueberham, M. K. Brückner, G. Seeger, T. Arendt, and U. Gärtner, “Different dendrite and dendritic spine alterations in basal and apical arbors in mutant human amyloid precursor protein transgenic mice,” Brain Res. 1099, 189–198 (2006).
[Crossref]
[PubMed]
B. J. Bacskai, S. T. Kajdasz, R. H. Christie, C. Carter, D. Games, P. Seubert, D. Schenk, and B. T. Hyman, “Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy,” Nat. Med. 7, 369–372 (2001).
[Crossref]
[PubMed]
O. A. Shemesh, H. Erez, I Ginzburg, and M. E. Spira, “Tau-induced traffic jam reflect organelles accumulation at points of microtubule polar mismatching,” Traffic 9, 458–471 (2008).
[Crossref]
[PubMed]
S. Oddo, A. Caccamo, J. D. Shepherd, M. P. Murphy, T. E. Golde, R. Kayed, R. Metherate, M. P. Mattson, Y. Akbari, and F. M. LaFerla, “Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction,” Neuron 39, 409–421 (2003).
[Crossref]
[PubMed]
D. R. Borchelt, T. Ratovitski, J. van Lare, M. K. Lee, V. Gonzales, N. A. Jenkins, N. G. Copeland, D. L. Price, and S. S. Sisodia, “Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins,” Neuron 19, 939–945 (1997).
[Crossref]
[PubMed]
J. Lewis, D. W. Dickson, W. L. Lin, L. Chisholm, A. Corral, G. Jones, S. H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton, and E. McGowan, “Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP,” Science 293, 1487–1491 (2001).
[Crossref]
[PubMed]
T. L. Spires, M. Meyer-Leuhmann, E. A. Stern, P. J. McLean, J. Skoch, P. T. Nguyen, B. J. Bacskai, and B. T. Hyman, “Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy,” J. Neurosci. 25, 7278–7287 (2005).
[Crossref]
[PubMed]
C. S. Atwood, R. N. Martins, M. A. Smith, and G. Perry, “Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins,” Peptides 23, 1343–1350 (2002).
[Crossref]
[PubMed]
O. A. Shemesh, H. Erez, I Ginzburg, and M. E. Spira, “Tau-induced traffic jam reflect organelles accumulation at points of microtubule polar mismatching,” Traffic 9, 458–471 (2008).
[Crossref]
[PubMed]
T. L. Spires, M. Meyer-Leuhmann, E. A. Stern, P. J. McLean, J. Skoch, P. T. Nguyen, B. J. Bacskai, and B. T. Hyman, “Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy,” J. Neurosci. 25, 7278–7287 (2005).
[Crossref]
[PubMed]
M. Meyer-Luehmann, T. L. Spires-Jones, C. Prada, M. Garcia-Alloza, A. de Calignon, A. Rozkalne, J. Koenigsknecht-Talboo, D. M. Holtzman, B. J. Bacskai, and B. T. Hyman, “Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer’s disease,” Nature 451, 720–724 (2008).
[Crossref]
[PubMed]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23, 577–583 (2005).
[Crossref]
[PubMed]
T. L. Spires, M. Meyer-Leuhmann, E. A. Stern, P. J. McLean, J. Skoch, P. T. Nguyen, B. J. Bacskai, and B. T. Hyman, “Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy,” J. Neurosci. 25, 7278–7287 (2005).
[Crossref]
[PubMed]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23, 577–583 (2005).
[Crossref]
[PubMed]
W. Denk, J. H. Strickler, and W. W. Webb, “Two-photon laser scanning fluorescence microscopy,” Science 248, 73–76 (1990).
[Crossref]
[PubMed]
B. Sakmann and G. Stuart, “Patch-pipette recordings from the soma, dendrites and, and axon of neurons in brain slices,” in Single-Channel Recording, 2nd ed., B. Sakmann and E. Neher, eds. (Plenum, 1983), pp. 199–211.
R. H. Takahashi, T. A. Milner, F. Li, E. E. Nam, M. A. Edgar, H. Yamaguchi, M. F. Beal, H. Xu, P. Greengard, and G. K. Gouras, “Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology,” Am. J. Pathol. 161, 1869–1879 (2002).
[Crossref]
[PubMed]
R. H. Takahashi, E. Capetillo-Zarate, M. T. Lin, T. A. Milner, and G. K. Gouras, “Co-occurrence of Alzheimer’s disease beta-amyloid and tau pathologies at synapses,” Neurobiol. Aging, in press (2008).
T. Takano, X. Han, R. Deane, B. Zlokovic, and M. Nedergaard, “Two-photon imaging of astrocytic Ca2+ signaling and the microvasculature in experimental mice models of Alzheimer’s disease,” Ann. N.Y. Acad. Sci. 1097, 40–50 (2007).
[Crossref]
[PubMed]
D. R. Thal, E. Ghebremedhin, C. Haass, and C. Schultz, “UV light-induced autofluorescence of full-length abeta-protein deposits in the human brain,” Clin. Neuropathol. 21, 35–40 (2002).
[PubMed]
C. Ballatore, V. M. Lee, and J. Q. Trojanowski, “Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders,” Nat. Rev. Neurosci. 8, 663–672 (2007).
[Crossref]
[PubMed]
J. Grutzendler, K. Helmin, J. Tsai, and W. B. Gan, “Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer’s disease,” Ann. N. Y. Acad. Sci. 1097, 30–39 (2007).
[Crossref]
[PubMed]
J. Tsai, J. Grutzendler, K. Duff, and W. B. Gan, “Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal brances,” Nat. Neurosci. 7, 1181–1183 (2004).
[Crossref]
[PubMed]
M. D. Ikonomovic, W. E. Klunk, E. E. Abrahamson, C. A. Mathis, J. C. Price, N. D. Tsopelas, B. J. Lopresti, S. Ziolko, W. Bi, W. R. Paljug, M. L. Debnath, C. E. Hope, B. A. Isanski, R. L. Hamilton, and S. T. DeKosky, “Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease,” Brain 131, 1630–1645 (2008).
[Crossref]
[PubMed]
A. Alpár, U. Ueberham, M. K. Brückner, G. Seeger, T. Arendt, and U. Gärtner, “Different dendrite and dendritic spine alterations in basal and apical arbors in mutant human amyloid precursor protein transgenic mice,” Brain Res. 1099, 189–198 (2006).
[Crossref]
[PubMed]
H. D. Vishwasrao, A. A. Heikal, K. A. Kasischke, and W. W. Webb, “Conformational dependence of intracellular NADH on metabolic state revealed by associated fluorescence anisotropy,” J. Biol. Chem. 280, 25119–25126 (2005).
[Crossref]
[PubMed]
K. A. Kasischke, H. D. Vishwasrao, P. J. Fisher, W. R. Zipfel, and W. W. Webb, “Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis,” Science 305, 99–103 (2004).
[Crossref]
[PubMed]
D. A. Dombeck, K. A. Kasischke, H. D. Vishwasrao, M. Ingelsson, B. T. Hyman, and W. W. Webb, “Uniform polarity microtubule assemblies imaged in native brain tissue by second-harmonic generation microscopy,” Proc. Natl. Acad. Sci. 100, 7081–7086 (2003).
[Crossref]
[PubMed]
A. C. Kwan, D. A. Dombeck, and W. W. Webb, “Polarized microtubule arrays in apical dendrites and axons,” Proc. Natl. Acad. Sci. 105, 11370–11375 (2008).
[Crossref]
[PubMed]
H. D. Vishwasrao, A. A. Heikal, K. A. Kasischke, and W. W. Webb, “Conformational dependence of intracellular NADH on metabolic state revealed by associated fluorescence anisotropy,” J. Biol. Chem. 280, 25119–25126 (2005).
[Crossref]
[PubMed]
K. A. Kasischke, H. D. Vishwasrao, P. J. Fisher, W. R. Zipfel, and W. W. Webb, “Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis,” Science 305, 99–103 (2004).
[Crossref]
[PubMed]
M. J. Levene, D. A. Dombeck, K. A. Kasischke, R. P. Molloy, and W. W. Webb, “In vivo multiphoton microscopy of deep brain tissue,” J. Neurophysiol. 91, 1908–1912 (2004).
[Crossref]
W. R. Zipfel, R. M. Williams, R. Christie, A. Y. Nikitin, B. T. Hyman, and W. W. Webb, “Live tissue intrinsic emission microscopy using multiphoton-excited native fluorescence and second harmonic generation,” Proc. Natl. Acad. Sci. 100, 7075–7080 (2003).
[Crossref]
[PubMed]
D. A. Dombeck, K. A. Kasischke, H. D. Vishwasrao, M. Ingelsson, B. T. Hyman, and W. W. Webb, “Uniform polarity microtubule assemblies imaged in native brain tissue by second-harmonic generation microscopy,” Proc. Natl. Acad. Sci. 100, 7081–7086 (2003).
[Crossref]
[PubMed]
W. R. Zipfel, R. M. Williams, and W. W. Webb, “Nonlinear magic: multiphoton microscopy in the biosciences,” Nat. Biotechnol. 21, 1369–1377 (2003).
[Crossref]
[PubMed]
R. H. Christie, B. J. Bacskai, W. R. Zipfel, R. M. Williams, S. T. Kajdasz, W. W. Webb, and B. T. Hyman, “Growth arrest of individual senile plaques in a model of Alzheimer’s disease observed by in vivo multiphoton microscopy,” J. Neurosci. 21, 858–864 (2001).
[PubMed]
W. Denk, J. H. Strickler, and W. W. Webb, “Two-photon laser scanning fluorescence microscopy,” Science 248, 73–76 (1990).
[Crossref]
[PubMed]
M. Hintersteiner, A. Enz, P. Frey, A. L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K. H. Wiederhold, and H. U. Gremlich, “In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe,” Nat. Biotechnol. 23, 577–583 (2005).
[Crossref]
[PubMed]
W. R. Zipfel, R. M. Williams, R. Christie, A. Y. Nikitin, B. T. Hyman, and W. W. Webb, “Live tissue intrinsic emission microscopy using multiphoton-excited native fluorescence and second harmonic generation,” Proc. Natl. Acad. Sci. 100, 7075–7080 (2003).
[Crossref]
[PubMed]
W. R. Zipfel, R. M. Williams, and W. W. Webb, “Nonlinear magic: multiphoton microscopy in the biosciences,” Nat. Biotechnol. 21, 1369–1377 (2003).
[Crossref]
[PubMed]
R. H. Christie, B. J. Bacskai, W. R. Zipfel, R. M. Williams, S. T. Kajdasz, W. W. Webb, and B. T. Hyman, “Growth arrest of individual senile plaques in a model of Alzheimer’s disease observed by in vivo multiphoton microscopy,” J. Neurosci. 21, 858–864 (2001).
[PubMed]
R. H. Takahashi, T. A. Milner, F. Li, E. E. Nam, M. A. Edgar, H. Yamaguchi, M. F. Beal, H. Xu, P. Greengard, and G. K. Gouras, “Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology,” Am. J. Pathol. 161, 1869–1879 (2002).
[Crossref]
[PubMed]
J. Lewis, D. W. Dickson, W. L. Lin, L. Chisholm, A. Corral, G. Jones, S. H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton, and E. McGowan, “Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP,” Science 293, 1487–1491 (2001).
[Crossref]
[PubMed]
R. H. Takahashi, T. A. Milner, F. Li, E. E. Nam, M. A. Edgar, H. Yamaguchi, M. F. Beal, H. Xu, P. Greengard, and G. K. Gouras, “Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology,” Am. J. Pathol. 161, 1869–1879 (2002).
[Crossref]
[PubMed]
K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole, “Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice,” Science 274, 99–102 (1996).
[Crossref]
[PubMed]
J. Lewis, D. W. Dickson, W. L. Lin, L. Chisholm, A. Corral, G. Jones, S. H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton, and E. McGowan, “Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP,” Science 293, 1487–1491 (2001).
[Crossref]
[PubMed]
K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole, “Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice,” Science 274, 99–102 (1996).
[Crossref]
[PubMed]
L. Qiang, W. Yu, A. Andreadis, M. Luo, and P. W. Baas, “Tau protects microtubules in the axon from severing by katanin,” J. Neurosci. 26, 3120–3129 (2006).
[Crossref]
[PubMed]
M. D. Ikonomovic, W. E. Klunk, E. E. Abrahamson, C. A. Mathis, J. C. Price, N. D. Tsopelas, B. J. Lopresti, S. Ziolko, W. Bi, W. R. Paljug, M. L. Debnath, C. E. Hope, B. A. Isanski, R. L. Hamilton, and S. T. DeKosky, “Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease,” Brain 131, 1630–1645 (2008).
[Crossref]
[PubMed]
K. A. Kasischke, H. D. Vishwasrao, P. J. Fisher, W. R. Zipfel, and W. W. Webb, “Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis,” Science 305, 99–103 (2004).
[Crossref]
[PubMed]
W. R. Zipfel, R. M. Williams, R. Christie, A. Y. Nikitin, B. T. Hyman, and W. W. Webb, “Live tissue intrinsic emission microscopy using multiphoton-excited native fluorescence and second harmonic generation,” Proc. Natl. Acad. Sci. 100, 7075–7080 (2003).
[Crossref]
[PubMed]
W. R. Zipfel, R. M. Williams, and W. W. Webb, “Nonlinear magic: multiphoton microscopy in the biosciences,” Nat. Biotechnol. 21, 1369–1377 (2003).
[Crossref]
[PubMed]
R. H. Christie, B. J. Bacskai, W. R. Zipfel, R. M. Williams, S. T. Kajdasz, W. W. Webb, and B. T. Hyman, “Growth arrest of individual senile plaques in a model of Alzheimer’s disease observed by in vivo multiphoton microscopy,” J. Neurosci. 21, 858–864 (2001).
[PubMed]
T. Takano, X. Han, R. Deane, B. Zlokovic, and M. Nedergaard, “Two-photon imaging of astrocytic Ca2+ signaling and the microvasculature in experimental mice models of Alzheimer’s disease,” Ann. N.Y. Acad. Sci. 1097, 40–50 (2007).
[Crossref]
[PubMed]